Tritonix.ai

News / Korea / yonhap_finance

NeoImmuneTech Hits Daily Limit for Second Straight Day on US Licensing Deal

Health Technology · Biotechnology · yonhap_finance · 2026-08-21

950220

NeoImmuneTech shares surged to the daily limit for two consecutive days following a licensing agreement with US-based Tolerance Bio for its NT-I7 therapy.

What Happened

Licensing Agreement: NeoImmuneTech has signed a deal to transfer exclusive development and commercialization rights for its immunotherapy agent, NT-I7, to the US biotech firm Tolerance Bio. This marks the company's first major licensing agreement since its KOSDAQ debut.

Therapeutic Focus: NT-I7 acts as a T-cell amplifier designed to eliminate cancer and infected cells. The partnership specifically targets indications related to thymic dysfunction, including immune reconstitution for HIV patients.

Deal Structure: The agreement is valued at approximately 367 billion KRW in milestone payments, alongside a 4% equity stake in Tolerance Bio. The company will also receive tiered royalties based on annual net sales generated from the product.

Market Reaction: The announcement triggered strong investor demand, driving the stock to the daily upper limit for two consecutive trading sessions. Shares closed at 2,850 KRW on the 21st as the market reacted positively to the news.

Read original

More in Health Technology

Taiwan Innovation Board Boosts Biotech Sector with Focus on Precision Health

Health Technology · economic_daily · 2026-08-21

The Taiwan Innovation Board is accelerating the capitalization of the precision health sector by supporting startups in AI diagnostics, genomics, and cell therapy.

Daehwa Pharmaceutical Shares Surge Over 10% in After-Hours Trading

Health Technology · yonhap_finance · 2026-08-21

Daehwa Pharmaceutical experienced a sharp rise of over 10% in after-hours trading, drawing significant attention from market participants.

067080

AprilBio Shares Surge Over 10% in After-Hours Trading

Health Technology · yonhap_finance · 2026-08-21

Shares of KOSDAQ-listed AprilBio experienced a significant rally in after-hours trading, climbing more than 10% following the close of the regular session.

397030

Latest in Korea

South Korea Extends Fuel Price Caps Amid Middle East Tensions

Energy Minerals · yonhap_finance · 2026-08-21

The South Korean government has decided to maintain current gasoline and diesel price caps for another four weeks to mitigate inflation and energy volatility.

Foreign Investors' Weekly Top Buys on KOSDAQ: PharmaResearch and Alteogen Lead

Electronic Technology · yonhap_finance · 2026-08-21

During the week of August 17-21, 2026, foreign investors heavily accumulated shares of PharmaResearch and Alteogen on the KOSDAQ, while offloading EO Technics.

Institutional Investors Target Silicon2 and HPSP in Weekly KOSDAQ Trading

Technology Services · yonhap_finance · 2026-08-21

Institutional investors led the KOSDAQ market during the week of August 17-21, 2026, with heavy buying in Silicon2 and HPSP, while offloading Robotis.

Foreign Investors Accumulate Samsung Electronics and SK Hynix, Offload Samsung Electro-Mechanics

Electronic Technology · yonhap_finance · 2026-08-21

During the week of August 17-21, 2026, foreign investors heavily bought Samsung Electronics and SK Hynix on the KOSPI, while selling off Samsung Electro-Mechanics.